Raymond James Financial’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.2M Sell
598,235
-1,566,355
-72% -$70M 0.01% 1388
2026
Q2
$101M Sell
2,164,590
-67,776
-3% -$3.14M 0.03% 566
2026
Q1
$109M Sell
2,232,366
-325,797
-13% -$15.2M 0.03% 478
2025
Q4
$112M Sell
2,558,163
-520,179
-17% -$23.7M 0.03% 461
2025
Q3
$139M Sell
3,078,342
-158,286
-5% -$6.95M 0.04% 378
2025
Q2
$141M Buy
3,236,628
+1,204,364
+59% +$53.6M 0.05% 353
2025
Q1
$93.6M Buy
2,032,264
+1,387,134
+215% +$58M 0.04% 460
2024
Q4
$24.3M Buy
+645,130
New +$25M 0.01% 1173

Other funds holding EXC

Raymond James Financial's EXC Position: Q3 2026 in Review

Raymond James Financial reduced its Exelon (EXC) stake by 72% in Q3 2026, selling an estimated $70M and leaving 598,235 shares worth $24.2M. The position accounts for 0.01% of the portfolio, ranked #1388.

Raymond James Financial first reported a position in EXC in Q4 2024 and has held it in 8 quarters since. The position peaked at $141M in Q2 2025. 1,245 funds tracked by Wall St. Rank hold EXC as of Q3 2026.

  • Raymond James Financial held 598,235 shares of Exelon worth $24.2M as of Q3 2026.
  • Raymond James Financial sold 1,566,355 Exelon shares in Q3 2026, an estimated $70M.
  • Exelon made up 0.01% of Raymond James Financial's portfolio in Q3 2026, its #1388 holding.
  • Raymond James Financial first reported a position in Exelon in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Exelon position peaked at $141M in Q2 2025.
  • 1,245 funds tracked by Wall St. Rank held Exelon as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.